225 related articles for article (PubMed ID: 23741434)
1. Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells.
Zhang J; Chen YL; Ji G; Fang W; Gao Z; Liu Y; Wang J; Ding X; Gao F
PLoS One; 2013; 8(5):e64954. PubMed ID: 23741434
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells.
Park GB; Kim D; Kim YS; Kim JW; Sun H; Roh KH; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5162-73. PubMed ID: 26244291
[TBL] [Abstract][Full Text] [Related]
4. Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option.
Smolle E; Taucher V; Petru E; Haybaeck J
Anticancer Res; 2014 Apr; 34(4):1519-30. PubMed ID: 24692678
[TBL] [Abstract][Full Text] [Related]
5. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition.
Noguchi S; Eitoku M; Moriya S; Kondo S; Kiyosawa H; Watanabe T; Suganuma N
Lung; 2015 Oct; 193(5):691-700. PubMed ID: 26286207
[TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
8. The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer.
Zhang L; Liu Z; Ma W; Wang B
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S86-91. PubMed ID: 24135248
[TBL] [Abstract][Full Text] [Related]
9. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
[TBL] [Abstract][Full Text] [Related]
11. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.
Nagai T; Arao T; Furuta K; Sakai K; Kudo K; Kaneda H; Tamura D; Aomatsu K; Kimura H; Fujita Y; Matsumoto K; Saijo N; Kudo M; Nishio K
Mol Cancer Ther; 2011 Jan; 10(1):169-77. PubMed ID: 21220499
[TBL] [Abstract][Full Text] [Related]
13. [Research advance on mechanism and application of HATs and HDACs in epithelial-mesenchymal transition of lung cancer].
Chang R; You J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):211-5. PubMed ID: 23601302
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
Park IH; Kang JH; Shin JM; Lee HM
PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
16. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
17. Effects of Antitumor Drug Sorafenib on Chick Embryo Development.
Cheng YS; Wang XY; Wang G; Li Y; Chen YL; Chuai ML; Lee KK; Ding XY; Yang XS
Anat Rec (Hoboken); 2015 Jul; 298(7):1271-81. PubMed ID: 25810088
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
20. D-4F, an apolipoprotein A-I mimetic, inhibits TGF-β1 induced epithelial-mesenchymal transition in human alveolar epithelial cell.
You J; Wang J; Xie L; Zhu C; Xiong J
Exp Toxicol Pathol; 2016 Oct; 68(9):533-541. PubMed ID: 27495007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]